What is the share price of Apollo Ingredients Ltd (APOLLOIN) today?
The share price of APOLLOIN as on 22nd June 2026 is ₹79.21. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Apollo Ingredients Ltd (APOLLOIN) share?
The past returns of Apollo Ingredients Ltd (APOLLOIN) share are- Past 1 week: 10.38%
- Past 1 month: 48.39%
- Past 3 months: 358.39%
- Past 6 months: 942.24%
- Past 1 year: 1358.75%
- Past 3 years: 1432.11%
- Past 5 years: 1759.39%
What are the peers or stocks similar to Apollo Ingredients Ltd (APOLLOIN)?
The peers or stocks similar to Apollo Ingredients Ltd (APOLLOIN) include:What is the market cap of Apollo Ingredients Ltd (APOLLOIN) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Apollo Ingredients Ltd (APOLLOIN) is ₹82.38 Cr as of 22nd June 2026.What is the 52 week high and low of Apollo Ingredients Ltd (APOLLOIN) share?
The 52-week high of Apollo Ingredients Ltd (APOLLOIN) is ₹79.21 and the 52-week low is ₹5.43.What is the PE and PB ratio of Apollo Ingredients Ltd (APOLLOIN) stock?
The P/E (price-to-earnings) ratio of Apollo Ingredients Ltd (APOLLOIN) is 116.03. The P/B (price-to-book) ratio is 11.79.Which sector does Apollo Ingredients Ltd (APOLLOIN) belong to?
Apollo Ingredients Ltd (APOLLOIN) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Apollo Ingredients Ltd (APOLLOIN) shares?
You can directly buy Apollo Ingredients Ltd (APOLLOIN) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Apollo Ingredients Ltd
APOLLOIN Share Price
BSE₹79.210.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
APOLLOIN Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
BadThe stock is in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
APOLLOIN Performance & Key Metrics
APOLLOIN Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 95.79 | 11.79 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 41.59 | 6.21 | 0.55% |
APOLLOIN Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
APOLLOIN Company Profile
Apollo Ingredients Ltd is an Indian healthcare solutions company engaged in manufacturing ayurvedic, homeopathic, and allopathic medicines, operating hospitals, diagnostic centers, wellness centers, and providing healthcare support services including medical audits and facility management.
APOLLOHOSP
PE Ratio
62.71
62.71
1Y Return
20.86%
20.86%
Buy Reco %
86.21
86.21
MAXHEALTH
PE Ratio
73.89
73.89
1Y Return
7.99%
7.99%
Buy Reco %
82.61
82.61
FORTIS
PE Ratio
70.72
70.72
1Y Return
29.31%
29.31%
Buy Reco %
84.21
84.21
ASTERDM
PE Ratio
105.19
105.19
1Y Return
37.77%
37.77%
Buy Reco %
100.00
100.00
PE Ratio
48.03
48.03
1Y Return
4.04%
4.04%
Buy Reco %
85.71
85.71
APOLLOIN Forecast
APOLLOIN Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
APOLLOIN
APOLLOIN
Income
Balance Sheet
Cash Flow
Quarterly Normal View
APOLLOIN Income Statement
APOLLOIN Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 1.00 | 0.50 | 0.80 | 1.09 | 0.69 | 0.57 | 0.57 | 2.77 | 1.07 | ||||||||||
Operating & Other expenses | 0.03 | 0.81 | 0.50 | 0.99 | 0.96 | 0.53 | 0.67 | 0.54 | 1.90 | 0.91 | ||||||||||
EBITDA | -0.03 | 0.19 | 0.00 | -0.19 | 0.13 | 0.16 | -0.10 | 0.03 | 0.87 | 0.16 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | ||||||||||
| PBIT | -0.03 | 0.19 | 0.00 | -0.19 | 0.13 | 0.16 | -0.10 | 0.03 | 0.87 | 0.06 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | -0.03 | 0.19 | 0.00 | -0.19 | 0.13 | 0.16 | -0.10 | 0.03 | 0.87 | 0.06 | ||||||||||
| Taxes & Other Items | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Net Income | -0.03 | 0.17 | 0.00 | -0.19 | 0.13 | 0.16 | -0.10 | 0.03 | 0.87 | 0.06 | ||||||||||
| EPS | -0.65 | 4.36 | -0.04 | -4.83 | 3.39 | 4.10 | -2.70 | 0.02 | 0.83 | 0.06 |
APOLLOIN Company Updates
FY 2023FY 2023
APOLLOIN Stock Peers
APOLLOIN Past Performance & Peer Comparison
APOLLOIN Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Apollo Ingredients Ltd | 116.03 | 11.79 | — |
| Apollo Hospitals Enterprise Ltd | 62.71 | 10.97 | 0.24% |
| Max Healthcare Institute Ltd | 73.89 | 11.36 | 0.18% |
| Fortis Healthcare Ltd | 70.72 | 8.03 | 0.10% |
APOLLOIN Stock Price Comparison
Compare APOLLOIN with any stock or ETFCompare APOLLOIN with any stock or ETF
APOLLOIN
APOLLOIN Holdings
APOLLOIN Shareholdings
APOLLOIN Promoter Holdings Trend
APOLLOIN Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
APOLLOIN Institutional Holdings Trend
APOLLOIN Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
APOLLOIN Shareholding Pattern
APOLLOIN Shareholding Pattern
APOLLOIN Shareholding History
APOLLOIN Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing APOLLOIN stock
smallcases containing APOLLOIN stock
Looks like this stock is not in any smallcase yet.
APOLLOIN Events
APOLLOIN Events
APOLLOIN Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
APOLLOIN has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
APOLLOIN Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
APOLLOIN has not given any dividends in last 5 years
APOLLOIN Dividends
APOLLOIN Dividends
Hmm, looks like data is unavailable here. Please come back after some timeAPOLLOIN Stock News & Opinions
APOLLOIN Stock News & Opinions
Articles & Videos
Corporate
Corporate
Apollo Ingredients to conduct AGMApollo Ingredients announced that the 46th Annual General Meeting(AGM) of the company will be held on 29 June 2026.
2 weeks agoCapital Market - Live
Earnings
Earnings
Apollo Ingredients standalone net profit declines 56.25% in the March 2026 quarterNet profit of Apollo Ingredients declined 56.25% to Rs 0.07 crore in the quarter ended March 2026 as against Rs 0.16 crore during the previous quarter ended March 2025. Sales rose 46.38% to Rs 1.01 crore in the quarter ended March 2026 as against Rs 0.69 crore during the previous quarter ended March 2025. For the full year,net profit rose 610.00% to Rs 0.71 crore in the year ended March 2026 as against Rs 0.10 crore during the previous year ended March 2025. Sales rose 59.61% to Rs 4.90 crore in the year ended March 2026 as against Rs 3.07 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales1.010.69 46 4.903.07 60 OPM %9.9023.19 -18.983.91 - PBDT0.170.16 6 1.060.13 715 PBT0.070.16 -56 0.960.13 638 NP0.070.16 -56 0.710.10 610 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Corporate
Apollo Ingredients schedules board meetingApollo Ingredients will hold a meeting of the Board of Directors of the Company on 15 May 2026.
1 month agoCapital Market - Live
Corporate
Corporate
Apollo Ingredients to hold board meetingApollo Ingredients will hold a meeting of the Board of Directors of the Company on 5 March 2026.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Earnings
Apollo Ingredients standalone net profit rises 521.43% in the December 2025 quarterNet profit of Apollo Ingredients rose 521.43% to Rs 0.87 crore in the quarter ended December 2025 as against Rs 0.14 crore during the previous quarter ended December 2024. Sales rose 154.13% to Rs 2.77 crore in the quarter ended December 2025 as against Rs 1.09 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales2.771.09 154 OPM %31.4112.84 - PBDT0.870.14 521 PBT0.870.14 521 NP0.870.14 521 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Corporate
Apollo Ingredients to discuss resultsApollo Ingredients will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Earnings
Apollo Ingredients reports standalone net profit of Rs 0.02 crore in the September 2025 quarterNet profit of Apollo Ingredients reported to Rs 0.02 crore in the quarter ended September 2025 as against net loss of Rs 0.19 crore during the previous quarter ended September 2024. Sales declined 28.75% to Rs 0.57 crore in the quarter ended September 2025 as against Rs 0.80 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales0.570.80 -29 OPM %3.51-23.75 - PBDT0.02-0.19 LP PBT0.02-0.19 LP NP0.02-0.19 LP Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Apollo Ingredients to conduct board meetingApollo Ingredients will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Apollo Ingredients to conduct AGMApollo Ingredients announced that the Annual General Meeting(AGM) of the company will be held on 27 September 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Corporate
Apollo Ingredients to convene board meetingApollo Ingredients will hold a meeting of the Board of Directors of the Company on 2 September 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -7.1%, vs industry avg of 13.41%
Over the last 5 years, market share decreased from 0.01% to 0%
Over the last 5 years, net income has grown at a yearly rate of -8.97%, vs industry avg of 42.52%